Table 1.
Clinicopathological characteristics of ANCR expression in NPC patients
| Features | Number | ANCR mRNA level (mean±SD) | P-value |
|---|---|---|---|
|
| |||
| 30 | |||
|
| |||
| Gender | |||
| Male | 17 | 1.704±1.172 | 0.8873 |
| Female | 13 | 1.765±1.082 | |
|
| |||
| Age, years | |||
| ≥60 | 23 | 1.694±1.060 | 0.7600 |
| <60 | 7 | 1.850±1.345 | |
|
| |||
| Tumor size | |||
| ≥5 cm | 16 | 2.138±1.174 | 0.0267 |
| <5 cm | 14 | 1.207±0.890 | |
|
| |||
| Lymph node status | |||
| N0 | 18 | 1.825±1.086 | 0.5910 |
| N1–3 | 12 | 1.588±1.190 | |
|
| |||
| Distant metastasis | |||
| M0 | 28 | 1.686±1.113 | 0.4415 |
| M1 | 2 | 2.350±1.250 | |
|
| |||
| TNM stage | |||
| I–II | 13 | 2.236±1.171 | 0.004 |
| III | 17 | 1.069±0.637 | |
Abbreviations: ANCR, antidifferentiation noncoding RNA; NPC, nasopharyngeal carcinoma.